REGENERON PHARMACEUTICALS, INC. Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for July 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 179.13 | 10,000 | 1,791,300 | 13,500 | |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 52.03 | 2,224 | 115,715 | 0 | |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 658.00 | 11 | 7,238 | 17,501 | 17.5 K to 17.5 K (-0.06 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 647.79 | 82 | 53,119 | 17,512 | 17.6 K to 17.5 K (-0.47 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 646.82 | 155 | 100,257 | 17,594 | 17.7 K to 17.6 K (-0.87 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 645.33 | 72 | 46,464 | 17,749 | 17.8 K to 17.7 K (-0.40 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 644.57 | 303 | 195,305 | 17,821 | 18.1 K to 17.8 K (-1.67 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 643.49 | 691 | 444,652 | 18,124 | 18.8 K to 18.1 K (-3.67 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 642.39 | 676 | 434,256 | 18,815 | 19.5 K to 18.8 K (-3.47 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 641.58 | 855 | 548,551 | 19,491 | 20.3 K to 19.5 K (-4.20 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 640.61 | 113 | 72,389 | 20,346 | 20.5 K to 20.3 K (-0.55 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 639.64 | 75 | 47,973 | 20,459 | 20.5 K to 20.5 K (-0.37 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 638.51 | 306 | 195,384 | 20,534 | 20.8 K to 20.5 K (-1.47 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 637.88 | 154 | 98,234 | 20,840 | 21 K to 20.8 K (-0.73 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 636.56 | 216 | 137,497 | 20,994 | 21.2 K to 21 K (-1.02 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 52.03 | 2,224 | 115,715 | 21,210 | 19 K to 21.2 K (+11.71 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Payment of Exercise | F | 655.57 | 6,291 | 4,124,191 | 18,986 | 25.3 K to 19 K (-24.89 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 179.13 | 10,000 | 1,791,300 | 25,277 | 15.3 K to 25.3 K (+65.46 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 555.67 | 5,000 | 2,778,350 | 5,000 | |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 3,500 | 1,398,810 | 25,000 | |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 658.00 | 3 | 1,974 | 24,669 | 24.7 K to 24.7 K (-0.01 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 647.50 | 388 | 251,230 | 24,672 | 25.1 K to 24.7 K (-1.55 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 655.57 | 4,611 | 3,022,833 | 25,060 | 29.7 K to 25.1 K (-15.54 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 555.67 | 5,000 | 2,778,350 | 29,671 | 24.7 K to 29.7 K (+20.27 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 655.57 | 2,802 | 1,836,907 | 24,671 | 27.5 K to 24.7 K (-10.20 %) |
Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 3,500 | 1,398,810 | 27,473 | 24 K to 27.5 K (+14.60 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | M | 30.63 | 13,000 | 398,190 | 13,736 | |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 639.55 | 79 | 50,524 | 41,951 | 42 K to 42 K (-0.19 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 638.96 | 239 | 152,711 | 42,030 | 42.3 K to 42 K (-0.57 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 637.48 | 182 | 116,021 | 42,269 | 42.5 K to 42.3 K (-0.43 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 635.46 | 175 | 111,206 | 42,451 | 42.6 K to 42.5 K (-0.41 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 634.18 | 89 | 56,442 | 42,626 | 42.7 K to 42.6 K (-0.21 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 633.02 | 95 | 60,137 | 42,715 | 42.8 K to 42.7 K (-0.22 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 632.12 | 679 | 429,209 | 42,810 | 43.5 K to 42.8 K (-1.56 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 631.32 | 578 | 364,903 | 43,489 | 44.1 K to 43.5 K (-1.31 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 630.77 | 264 | 166,523 | 44,067 | 44.3 K to 44.1 K (-0.60 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 629.58 | 852 | 536,402 | 44,331 | 45.2 K to 44.3 K (-1.89 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 628.50 | 950 | 597,075 | 45,183 | 46.1 K to 45.2 K (-2.06 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 626.66 | 83 | 52,013 | 46,133 | 46.2 K to 46.1 K (-0.18 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 625.05 | 4 | 2,500 | 46,216 | 46.2 K to 46.2 K (-0.01 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 624.77 | 487 | 304,263 | 46,220 | 46.7 K to 46.2 K (-1.04 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 622.51 | 1 | 623 | 46,707 | 46.7 K to 46.7 K (0.00 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 621.06 | 113 | 70,180 | 46,708 | 46.8 K to 46.7 K (-0.24 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 620.94 | 81 | 50,296 | 46,821 | 46.9 K to 46.8 K (-0.17 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 619.28 | 162 | 100,323 | 46,902 | 47.1 K to 46.9 K (-0.34 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 618.39 | 255 | 157,689 | 47,064 | 47.3 K to 47.1 K (-0.54 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 617.64 | 304 | 187,763 | 47,319 | 47.6 K to 47.3 K (-0.64 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 616.34 | 256 | 157,783 | 47,623 | 47.9 K to 47.6 K (-0.53 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 615.59 | 203 | 124,965 | 47,879 | 48.1 K to 47.9 K (-0.42 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 614.62 | 178 | 109,402 | 48,082 | 48.3 K to 48.1 K (-0.37 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Payment of Exercise | F | 623.98 | 6,691 | 4,175,050 | 48,260 | 55 K to 48.3 K (-12.18 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Buy | M | 30.63 | 13,000 | 398,190 | 54,951 | 42 K to 55 K (+30.99 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 633.28 | 441 | 279,276 | 41,951 | 42.4 K to 42 K (-1.04 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 632.65 | 680 | 430,202 | 42,392 | 43.1 K to 42.4 K (-1.58 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 631.45 | 861 | 543,678 | 43,072 | 43.9 K to 43.1 K (-1.96 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 630.50 | 1,423 | 897,202 | 43,933 | 45.4 K to 43.9 K (-3.14 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 629.62 | 883 | 555,954 | 45,356 | 46.2 K to 45.4 K (-1.91 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 628.32 | 259 | 162,735 | 46,239 | 46.5 K to 46.2 K (-0.56 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 627.54 | 657 | 412,294 | 46,498 | 47.2 K to 46.5 K (-1.39 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 626.63 | 1,003 | 628,510 | 47,155 | 48.2 K to 47.2 K (-2.08 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 625.86 | 173 | 108,274 | 48,158 | 48.3 K to 48.2 K (-0.36 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 624.47 | 370 | 231,054 | 48,331 | 48.7 K to 48.3 K (-0.76 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 623.66 | 740 | 461,508 | 48,701 | 49.4 K to 48.7 K (-1.50 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 622.74 | 333 | 207,372 | 49,441 | 49.8 K to 49.4 K (-0.67 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 621.98 | 81 | 50,380 | 49,774 | 49.9 K to 49.8 K (-0.16 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 620.64 | 96 | 59,581 | 49,855 | 50 K to 49.9 K (-0.19 %) |
Jul 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 640.50 | 579 | 370,850 | 23,973 | 24.6 K to 24 K (-2.36 %) |
Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 3,000 | 1,198,980 | 28,500 | |
Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 642.46 | 2,421 | 1,555,396 | 24,552 | 27 K to 24.6 K (-8.98 %) |
Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 3,000 | 1,198,980 | 26,973 | 24 K to 27 K (+12.51 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 555.67 | 10,000 | 5,556,700 | 10,000 | |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 2,500 | 999,150 | 31,500 | |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 650.41 | 3 | 1,951 | 23,973 | 24 K to 24 K (-0.01 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 648.54 | 94 | 60,963 | 23,976 | 24.1 K to 24 K (-0.39 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 646.18 | 37 | 23,909 | 24,070 | 24.1 K to 24.1 K (-0.15 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 645.99 | 57 | 36,821 | 24,107 | 24.2 K to 24.1 K (-0.24 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 643.84 | 104 | 66,959 | 24,164 | 24.3 K to 24.2 K (-0.43 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 642.93 | 48 | 30,861 | 24,268 | 24.3 K to 24.3 K (-0.20 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 640.32 | 43 | 27,534 | 24,316 | 24.4 K to 24.3 K (-0.18 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 639.88 | 80 | 51,190 | 24,359 | 24.4 K to 24.4 K (-0.33 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 638.99 | 45 | 28,755 | 24,439 | 24.5 K to 24.4 K (-0.18 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 637.40 | 40 | 25,496 | 24,484 | 24.5 K to 24.5 K (-0.16 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 636.50 | 585 | 372,353 | 24,524 | 25.1 K to 24.5 K (-2.33 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 634.14 | 24 | 15,219 | 25,109 | 25.1 K to 25.1 K (-0.10 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 640.88 | 2,019 | 1,293,937 | 25,133 | 27.2 K to 25.1 K (-7.44 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 2,500 | 999,150 | 27,152 | 24.7 K to 27.2 K (+10.14 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 640.88 | 9,321 | 5,973,642 | 24,652 | 34 K to 24.7 K (-27.44 %) |
Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 555.67 | 10,000 | 5,556,700 | 33,973 | 24 K to 34 K (+41.71 %) |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 33.42 | 7,500 | 250,650 | 0 | |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 650.00 | 1,500 | 975,000 | 4,700 | 6.2 K to 4.7 K (-24.19 %) |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 651.09 | 200 | 130,218 | 400 | 600 to 400 (-33.33 %) |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 650.32 | 800 | 520,256 | 600 | 1.4 K to 600 (-57.14 %) |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 650.00 | 500 | 325,000 | 1,150 | 1.7 K to 1.2 K (-30.30 %) |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 650.00 | 7,500 | 4,875,000 | 115,415 | 122.9 K to 115.4 K (-6.10 %) |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 33.42 | 7,500 | 250,650 | 122,915 | 115.4 K to 122.9 K (+6.50 %) |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Option Exercise | M | 391.92 | 1,706 | 668,616 | 5,117 | |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 650.00 | 1,706 | 1,108,900 | 643 | 2.3 K to 643 (-72.63 %) |
Jul 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Buy | M | 391.92 | 1,706 | 668,616 | 2,349 | 643 to 2.3 K (+265.32 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 413.33 | 3,613 | 1,493,361 | 7,225 | |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 612.29 | 400 | 244,916 | 643 | 1 K to 643 (-38.35 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 607.35 | 200 | 121,470 | 1,043 | 1.2 K to 1 K (-16.09 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 624.19 | 6 | 3,745 | 1,243 | 1.2 K to 1.2 K (-0.48 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 623.07 | 100 | 62,307 | 1,249 | 1.3 K to 1.2 K (-7.41 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 616.49 | 200 | 123,298 | 1,349 | 1.5 K to 1.3 K (-12.91 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 615.23 | 100 | 61,523 | 1,549 | 1.6 K to 1.5 K (-6.06 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 609.51 | 200 | 121,902 | 1,649 | 1.8 K to 1.6 K (-10.82 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 608.59 | 319 | 194,140 | 1,849 | 2.2 K to 1.8 K (-14.71 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 605.78 | 401 | 242,918 | 2,168 | 2.6 K to 2.2 K (-15.61 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 604.82 | 960 | 580,627 | 2,569 | 3.5 K to 2.6 K (-27.20 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 603.39 | 627 | 378,326 | 3,529 | 4.2 K to 3.5 K (-15.09 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 601.70 | 100 | 60,170 | 4,156 | 4.3 K to 4.2 K (-2.35 %) |
Jul 02 2020 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 413.33 | 3,613 | 1,493,361 | 4,256 | 643 to 4.3 K (+561.90 %) |